Outcomes in the Treatment of Major Depressive Disorder

[1]  M. Thase,et al.  Escitalopram in the treatment of major depressive disorder: A meta-analysis , 2009 .

[2]  M. Thase.  Do antidepressants really work? A clinicians’ guide to evaluating the evidence , 2008, Current psychiatry reports.

[3]  R. Schoevers,et al.  Short Psychodynamic Supportive Psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega‐analysis based on three Randomized Clinical Trials , 2008, Depression and anxiety.

[4]  R. Schoevers,et al.  Speed of action: the relative efficacy of short psychodynamic supportive psychotherapy and pharmacotherapy in the first 8 weeks of a treatment algorithm for depression. , 2008, Journal of affective disorders.

[5]  E. Schramm,et al.  Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients. , 2008, Journal of affective disorders.

[6]  M. Fava,et al.  The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study , 2008, Journal of clinical psychopharmacology.

[7]  M. Thase,et al.  Pharmacotherapy of mood disorders. , 2008, Annual review of clinical psychology.

[8]  R. Rosenthal,et al.  Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.

[9]  M. Thase,et al.  Efficacy of Duloxetine and Selective Serotonin Reuptake Inhibitors: Comparisons as Assessed by Remission Rates in Patients With Major Depressive Disorder , 2007, Journal of clinical psychopharmacology.

[10]  M. Fava,et al.  A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder , 2007, European psychiatry.

[11]  S. Gilbody,et al.  A meta-analysis of randomized trials of behavioural treatment of depression , 2007, Psychological Medicine.

[12]  T. Wilens,et al.  Impact of substance use disorder on ADHD and its treatment. , 2007, The Journal of clinical psychiatry.

[13]  R. Shelton,et al.  The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. , 2007, The Journal of clinical psychiatry.

[14]  P. Spinhoven,et al.  Combination Treatment for Acute Depression Is Superior Only when Psychotherapy Is Added to Medication , 2007, Psychotherapy and Psychosomatics.

[15]  S. Hollon,et al.  Extreme nonresponse in cognitive therapy: can behavioral activation succeed where cognitive therapy fails? , 2007, Journal of consulting and clinical psychology.

[16]  R. Berman,et al.  The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. , 2007, The Journal of clinical psychiatry.

[17]  R. Shelton,et al.  Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. , 2007, The Journal of clinical psychiatry.

[18]  I. Florea,et al.  A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder , 2007, Current medical research and opinion.

[19]  L. Clark,et al.  Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. , 2007, Journal of consulting and clinical psychology.

[20]  P. Joyce,et al.  Randomised controlled trial of interpersonal psychotherapy and cognitive–behavioural therapy for depression , 2007, British Journal of Psychiatry.

[21]  P. Joyce,et al.  Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression , 2007, British Journal of Psychiatry.

[22]  Elisabeth Schramm,et al.  An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. , 2007, The American journal of psychiatry.

[23]  Daniel J Buysse,et al.  Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression. , 2007, American Journal of Psychiatry.

[24]  S. Hollon,et al.  Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. , 2007, The American journal of psychiatry.

[25]  Harold Alan Pincus,et al.  Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. , 2007, JAMA.

[26]  P. Cuijpers,et al.  Behavioral activation treatments of depression: a meta-analysis. , 2007, Clinical psychology review.

[27]  C. Nemeroff,et al.  Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. , 2007, Archives of general psychiatry.

[28]  N. Frasure-smith,et al.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. , 2007, JAMA.

[29]  A. Nierenberg,et al.  Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study* , 2007, Current medical research and opinion.

[30]  M. Fava,et al.  A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder , 2007, European Neuropsychopharmacology.

[31]  G. Simon.  The antidepressant quandary--considering suicide risk when treating adolescent depression. , 2006, The New England journal of medicine.

[32]  R. Bagby,et al.  Attachment as moderator of treatment outcome in major depression: a randomized control trial of interpersonal psychotherapy versus cognitive behavior therapy. , 2006, Journal of consulting and clinical psychology.

[33]  M. Thase.  Preventing Relapse and Recurrence of Depression: A Brief Review of Therapeutic Options , 2006, CNS Spectrums.

[34]  Robert D Gibbons,et al.  The relationship between antidepressant prescription rates and rate of early adolescent suicide. , 2006, The American journal of psychiatry.

[35]  C. Roberts,et al.  Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. , 2006, The British journal of psychiatry : the journal of mental science.

[36]  B. Haight,et al.  A Double-blind Comparison Between Bupropion XL and Venlafaxine XR: Sexual Functioning, Antidepressant Efficacy, and Tolerability , 2006, Journal of clinical psychopharmacology.

[37]  H. Kraemer,et al.  Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder , 2006, Neuropsychopharmacology.

[38]  R. Kessler,et al.  Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. , 2006, The American journal of psychiatry.

[39]  C. Beyer,et al.  Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor , 2006, Journal of Pharmacology and Experimental Therapeutics.

[40]  David C. Atkins,et al.  Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. , 2006, Journal of consulting and clinical psychology.

[41]  M. Hotopf,et al.  Are all antidepressants really the same? The case of fluoxetine: a systematic review. , 2006, The Journal of clinical psychiatry.

[42]  R. Shelton,et al.  Treatment with Venlafaxine Extended Release After SSRI Nonresponse or Intolerance: A Randomized Comparison of Standard- and Higher-dosing Strategies , 2006, Journal of clinical psychopharmacology.

[43]  B. Lebowitz,et al.  Medication augmentation after the failure of SSRIs for depression. , 2006, The New England journal of medicine.

[44]  Maurizio Fava,et al.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. , 2006, The New England journal of medicine.

[45]  Sati Mazumdar,et al.  Maintenance treatment of major depression in old age. , 2006, The New England journal of medicine.

[46]  R. Lam,et al.  Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. , 2006, Journal of psychiatry & neuroscience : JPN.

[47]  F. Goodwin,et al.  ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth , 2006, Neuropsychopharmacology.

[48]  J. Markowitz,et al.  A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients. , 2005, Journal of affective disorders.

[49]  N. Richard,et al.  Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. , 2005, The Journal of clinical psychiatry.

[50]  C. Reynolds,et al.  Treatment of complicated grief: a randomized controlled trial. , 2005, JAMA.

[51]  R. DeRubeis,et al.  Cognitive therapy vs medications in the treatment of moderate to severe depression. , 2005, Archives of general psychiatry.

[52]  M. Thase,et al.  Cardiovascular Profile of Duloxetine, a Dual Reuptake Inhibitor of Serotonin and Norepinephrine , 2005, Journal of clinical psychopharmacology.

[53]  A. Szegedi,et al.  Mirtazapine: a review of its clinical efficacy and tolerability , 2005, Expert opinion on pharmacotherapy.

[54]  J. Dekker,et al.  Dose–effect relations in time-limited combined psycho-pharmacological treatment for depression , 2005, Psychological Medicine.

[55]  M Pope,et al.  Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial , 2005, Psychological Medicine.

[56]  M. Thase.  Therapeutic Alternatives for Difficult-to-Treat Depression: A Narrative Review of the State of the Evidence , 2004, CNS Spectrums.

[57]  J. Markowitz,et al.  Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. , 2004, Journal of consulting and clinical psychology.

[58]  M. Tohen,et al.  A Double-Blind, Randomized Study of Olanzapine and Olanzapine/Fluoxetine Combination for Major Depression With Psychotic Features , 2004, Journal of clinical psychopharmacology.

[59]  M. Posternak,et al.  Implications of using different cut-offs on symptom severity scales to define remission from depression , 2004, International Clinical Psychopharmacology.

[60]  J. Dekker,et al.  Psychotherapy alone and combined with pharmacotherapy in the treatment of depression , 2004, British Journal of Psychiatry.

[61]  C. Sánchez,et al.  R‐citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter , 2004, British journal of pharmacology.

[62]  J. Teasdale,et al.  Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. , 2004, Journal of consulting and clinical psychology.

[63]  S. Svensson,et al.  Escitalopram: Superior to Citalopram or a Chiral Chimera? , 2003, Psychotherapy and Psychosomatics.

[64]  B. Rothbaum,et al.  Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[65]  C. Nemeroff,et al.  Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity , 2003, Biological Psychiatry.

[66]  J. Markowitz,et al.  The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression , 2003, Biological Psychiatry.

[67]  Juned Siddique,et al.  Treating depression in predominantly low-income young minority women: a randomized controlled trial. , 2003, JAMA.

[68]  M. Keller,et al.  Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. , 2003, JAMA.

[69]  M. Abou-Saleh,et al.  Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study. , 2003, The British journal of psychiatry : the journal of mental science.

[70]  P. Cooper,et al.  Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression , 2003, British Journal of Psychiatry.

[71]  D. Kupfer,et al.  Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review , 2003, The Lancet.

[72]  N. Buckley,et al.  Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data , 2002, BMJ : British Medical Journal.

[73]  J. Markowitz,et al.  Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. , 2002, The Journal of clinical psychiatry.

[74]  N. Freemantle,et al.  Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. , 2002, The British journal of psychiatry : the journal of mental science.

[75]  R. Sysko,et al.  Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.

[76]  C. Byrne,et al.  Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. , 2002, Journal of affective disorders.

[77]  R. Spitzer,et al.  The PHQ-9 , 2001, Journal of General Internal Medicine.

[78]  J. Dekker,et al.  Combining psychotherapy and antidepressants in the treatment of depression. , 2001, Journal of affective disorders.

[79]  G. Eaves,et al.  Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. , 2001, Archives of general psychiatry.

[80]  M. Thase,et al.  Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors , 2001, British Journal of Psychiatry.

[81]  D. Klein,et al.  Flawed meta-analyses comparing psychotherapy with pharmacotherapy. , 2000, The American journal of psychiatry.

[82]  Z. Segal,et al.  Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. , 2000, Journal of consulting and clinical psychology.

[83]  D. Kupfer,et al.  Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression. , 2000, The American journal of psychiatry.

[84]  E. Smeraldi,et al.  Four-year follow-up study of sertraline and fluvoxamine in long-term treatment of unipolar subjects with high recurrence rate. , 2000, Journal of affective disorders.

[85]  J. Markowitz,et al.  A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. , 2000, The New England journal of medicine.

[86]  I. Anderson,et al.  Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. , 2000, Journal of affective disorders.

[87]  J. Teasdale,et al.  Prevention of relapse in residual depression by cognitive therapy: a controlled trial. , 1999, Archives of general psychiatry.

[88]  D. Kupfer,et al.  Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levels. , 1999, The American journal of psychiatry.

[89]  M. Schaffer,et al.  Treatment of Atypical Depression With Cognitive Therapy or Phenelzine A Double-blind, Placebo-Controlled Trial , 1999 .

[90]  M. Trivedi,et al.  Meta-Analysis of the Reversible Inhibitors of Monoamine Oxidase Type A Moclobemide and Brofaromine for the Treatment of Depression , 1999, Neuropsychopharmacology.

[91]  T. Einarson,et al.  Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials. , 1999, Clinical therapeutics.

[92]  D. Kupfer,et al.  Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. , 1999, The American journal of psychiatry.

[93]  D J Kupfer,et al.  Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. , 1999, JAMA.

[94]  J. Markowitz,et al.  The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. , 1998, The Journal of clinical psychiatry.

[95]  G. Fava,et al.  Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. , 1998, Archives of general psychiatry.

[96]  John A. Rice,et al.  A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. , 1998, Archives of general psychiatry.

[97]  A. Rush,et al.  Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder , 1998, Biological Psychiatry.

[98]  J. Markowitz,et al.  Treatment of depressive symptoms in human immunodeficiency virus-positive patients. , 1998, Archives of general psychiatry.

[99]  I. Blackburn,et al.  A meta-analysis of the effects of cognitive therapy in depressed patients. , 1998, Journal of affective disorders.

[100]  B. Pollock,et al.  Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. , 1998, JAMA.

[101]  D J Kupfer,et al.  Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. , 1997, Archives of general psychiatry.

[102]  W. Brown.  Is interpersonal psychotherapy superior to supportive psychotherapy? , 1996, The American journal of psychiatry.

[103]  Alan D. Lopez,et al.  Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study , 1996, Science.

[104]  P. Houck,et al.  Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. , 1996, The American journal of psychiatry.

[105]  J. Lave,et al.  Treating major depression in primary care practice. Eight-month clinical outcomes. , 1996, Archives of general psychiatry.

[106]  M. Thase,et al.  Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients. , 1996, American Journal of Psychiatry.

[107]  A. Rush,et al.  The Inventory of Depressive Symptomatology (IDS): psychometric properties , 1996, Psychological Medicine.

[108]  Jackie K. Gollan,et al.  A component analysis of cognitive-behavioral treatment for depression , 1996 .

[109]  R Ramana,et al.  Residual symptoms after partial remission: an important outcome in depression , 1995, Psychological Medicine.

[110]  D. Hedeker,et al.  Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. , 1995, Journal of Consulting and Clinical Psychology.

[111]  A. Rush,et al.  MAOIs in the Contemporary Treatment of Depression , 1995, Neuropsychopharmacology.

[112]  G. Clerc,et al.  A double‐blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia , 1994 .

[113]  P J McGrath,et al.  Atypical depression. A valid clinical entity? , 1993, The Psychiatric clinics of North America.

[114]  F. Song,et al.  Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. , 1993, BMJ.

[115]  D. Kupfer,et al.  Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. , 1993, Journal of affective disorders.

[116]  J. Mintz,et al.  Treatments of depression and the functional capacity to work. , 1992, Archives of general psychiatry.

[117]  M. Thase,et al.  Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. , 1992, The American journal of psychiatry.

[118]  D J Kupfer,et al.  Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. , 1991, Archives of general psychiatry.

[119]  D J Kupfer,et al.  Long-term treatment of depression. , 1991, The Journal of clinical psychiatry.

[120]  D. Kupfer,et al.  Five-year outcome for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.

[121]  Martin H. Teicher,et al.  Dr. Teicher and Associates Reply , 1990 .

[122]  Martin H. Teicher,et al.  Emergence of intense suicidal preoccupation during fluoxetine treatment. , 1990, The American journal of psychiatry.

[123]  W. Bowers.  Treatment of Depressed In-Patients , 1990, British Journal of Psychiatry.

[124]  G. Keitner,et al.  Cognitive-behavioral treatment of depressed inpatients , 1989 .

[125]  S D Imber,et al.  National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. , 1989, Archives of general psychiatry.

[126]  K. Dobson.  A meta-analysis of the efficacy of cognitive therapy for depression. , 1989, Journal of consulting and clinical psychology.

[127]  D. A. Shapiro,et al.  Prescriptive v. Exploratory Psychotherapy , 1987, British Journal of Psychiatry.

[128]  G. Henrich,et al.  Effectiveness of two psychological treatments for inpatients with severe and chronic depressions , 1986, Cognitive Therapy and Research.

[129]  G. Klerman,et al.  Differential symptom reduction by drugs and psychotherapy in acute depression. , 1979, Archives of general psychiatry.

[130]  G. Klerman,et al.  The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. , 1979, The American journal of psychiatry.

[131]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[132]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[133]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[134]  M. Thase,et al.  A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. , 2008, Journal of psychiatric research.

[135]  J. Amsterdam,et al.  The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability. , 2008, Journal of affective disorders.

[136]  M. Thase.  Are SNRIs more effective than SSRIs? A review of the current state of the controversy. , 2008, Psychopharmacology bulletin.

[137]  G. Alexopoulos,et al.  Double-Blind Comparison of Escitalopram and Duloxetine in the Acute Treatment of Major Depressive Disorder , 2007, Clinical drug investigation.

[138]  G. Plosker,et al.  Duloxetine: a review of its use in the treatment of major depressive disorder. , 2007, CNS drugs.

[139]  B. Lebowitz,et al.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.

[140]  M. Thase.  When are Psychotherapy and Pharmacotherapy Combinations the Treatment of Choice for Major Depressive Disorder? , 2004, Psychiatric Quarterly.

[141]  J. Dekker,et al.  Efficacy of combined therapy and pharmacotherapy for depressed patients with or without personality disorders. , 2003, Harvard review of psychiatry.

[142]  M. Thase,et al.  Remission as the critical outcome of depression treatment. , 2002, Psychopharmacology bulletin.

[143]  M. Thase.  The next step forward: a move toward evidence, and away from fear of the industry. , 2002, Psychopharmacology bulletin.

[144]  R. Shrivastava,et al.  Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. , 2001, The Journal of clinical psychiatry.

[145]  P. Haddad.  Antidepressant Discontinuation Syndromes , 2001, Drug safety.

[146]  J. Markowitz,et al.  Background information and treatment recommendations for patients with HIV/AIDS , 2000 .

[147]  D. Kupfer,et al.  Anxiety as a predictor of response to interpersonal psychotherapy for recurrent major depression: An exploratory investigation , 1998, Depression and anxiety.

[148]  C. Spencer,et al.  Milnacipran , 2012, Drugs.

[149]  I. Anderson.  SSRIs versus tricyclic antidepressants in depressed inpatients: A meta‐analysis of efficacy and tolerability , 1998, Depression and anxiety.

[150]  R. B. Carter,et al.  Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. , 1995, The Journal of clinical psychiatry.

[151]  D. Nutt,et al.  Selective serotonin reuptake inhibitors: meta‐analysis of discontinuation rates , 1994, International clinical psychopharmacology.

[152]  S. Hollon,et al.  Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients , 1977, Cognitive Therapy and Research.